310 related articles for article (PubMed ID: 22161837)
21. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.
Strizzi L; Bianco C; Normanno N; Seno M; Wechselberger C; Wallace-Jones B; Khan NI; Hirota M; Sun Y; Sanicola M; Salomon DS
J Cell Physiol; 2004 Nov; 201(2):266-76. PubMed ID: 15334661
[TBL] [Abstract][Full Text] [Related]
22. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
23. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.
Zhang W; Jiang B; Guo Z; Sardet C; Zou B; Lam CS; Li J; He M; Lan HY; Pang R; Hung IF; Tan VP; Wang J; Wong BC
Carcinogenesis; 2010 Jul; 31(7):1220-9. PubMed ID: 20460358
[TBL] [Abstract][Full Text] [Related]
24. Connexins: a junctional crossroad to breast cancer.
El-Saghir JA; El-Habre ET; El-Sabban ME; Talhouk RS
Int J Dev Biol; 2011; 55(7-9):773-80. PubMed ID: 22161833
[TBL] [Abstract][Full Text] [Related]
25. Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth.
Daniel CW; Strickland P; Friedmann Y
Dev Biol; 1995 Jun; 169(2):511-9. PubMed ID: 7781895
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of leucine zipper putative tumor suppressor 1 is associated with poor prognosis, increased cell motility and invasion, and epithelial-to-mesenchymal transition characteristics in human breast carcinoma.
Wang XX; Zhu Z; Su D; Lei T; Wu X; Fan Y; Li X; Zhao J; Fu L; Dong JT; Fu L
Hum Pathol; 2011 Oct; 42(10):1410-9. PubMed ID: 21419475
[TBL] [Abstract][Full Text] [Related]
27. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
[TBL] [Abstract][Full Text] [Related]
28. Cadherin-11 is expressed in invasive breast cancer cell lines.
Pishvaian MJ; Feltes CM; Thompson P; Bussemakers MJ; Schalken JA; Byers SW
Cancer Res; 1999 Feb; 59(4):947-52. PubMed ID: 10029089
[TBL] [Abstract][Full Text] [Related]
29. Regulation of urokinase plasminogen activator (uPA) activity by E-cadherin and hormones in mammary epithelial cells.
Sasaki CY; Lin H; Passaniti A
J Cell Physiol; 1999 Oct; 181(1):1-13. PubMed ID: 10457348
[TBL] [Abstract][Full Text] [Related]
30. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
[TBL] [Abstract][Full Text] [Related]
31. Mammary gland stem cells: current status and future challenges.
Fridriksdottir AJ; Petersen OW; Rønnov-Jessen L
Int J Dev Biol; 2011; 55(7-9):719-29. PubMed ID: 22161829
[TBL] [Abstract][Full Text] [Related]
32. E-cadherin and the cytoskeletal network in colorectal cancer development and metastasis.
Buda A; Pignatelli M
Cell Commun Adhes; 2011 Dec; 18(6):133-43. PubMed ID: 22176698
[TBL] [Abstract][Full Text] [Related]
33. P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model.
Ribeiro AS; Sousa B; Carreto L; Mendes N; Nobre AR; Ricardo S; Albergaria A; Cameselle-Teijeiro JF; Gerhard R; Söderberg O; Seruca R; Santos MA; Schmitt F; Paredes J
J Pathol; 2013 Apr; 229(5):705-18. PubMed ID: 23180380
[TBL] [Abstract][Full Text] [Related]
34. The mammary myoepithelial cell.
Moumen M; Chiche A; Cagnet S; Petit V; Raymond K; Faraldo MM; Deugnier MA; Glukhova MA
Int J Dev Biol; 2011; 55(7-9):763-71. PubMed ID: 21948739
[TBL] [Abstract][Full Text] [Related]
35. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton.
Jiang P; Enomoto A; Takahashi M
Cancer Lett; 2009 Nov; 284(2):122-30. PubMed ID: 19303207
[TBL] [Abstract][Full Text] [Related]
36. Tenascin in mammary gland development: from embryogenesis to carcinogenesis.
Sakakura T; Ishihara A; Yatani R
Cancer Treat Res; 1991; 53():383-400. PubMed ID: 1705813
[No Abstract] [Full Text] [Related]
37. The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes.
Sreekumar A; Roarty K; Rosen JM
Endocr Relat Cancer; 2015 Dec; 22(6):T161-76. PubMed ID: 26206777
[TBL] [Abstract][Full Text] [Related]
38. Precocious mammary gland development in P-cadherin-deficient mice.
Radice GL; Ferreira-Cornwell MC; Robinson SD; Rayburn H; Chodosh LA; Takeichi M; Hynes RO
J Cell Biol; 1997 Nov; 139(4):1025-32. PubMed ID: 9362520
[TBL] [Abstract][Full Text] [Related]
39. Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis.
Pelekanou V; Leclercq G
Int J Dev Biol; 2011; 55(7-9):869-78. PubMed ID: 22161842
[TBL] [Abstract][Full Text] [Related]
40. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.
Figueira AC; Gomes C; de Oliveira JT; Vilhena H; Carvalheira J; de Matos AJ; Pereira PD; Gärtner F
BMC Vet Res; 2014 Nov; 10():270. PubMed ID: 25424750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
